Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings.

Gold SM, Schulz H, Stein H, Solf K, Schulz KH, Heesen C.

J Neurol Sci. 2010 Mar 15;290(1-2):102-6. doi: 10.1016/j.jns.2009.10.020. Epub 2009 Nov 17.

PMID:
19922955
2.

Redefining functionality and treatment efficacy in multiple sclerosis.

Foley JF, Brandes DW.

Neurology. 2009 Jun 9;72(23 Suppl 5):S1-11. doi: 10.1212/WNL.0b013e3181a99bc2.

PMID:
19506262
3.

Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.

Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T.

Mult Scler. 2009 Jun;15(6):752-8. doi: 10.1177/1352458509103300.

PMID:
19482864
4.

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis.

Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A, Hoffmann F, Käfferlein W, Kausch U, Liedtke M, Kirchmeier J, Gmünd S, Richter A, Schicklmaier P, Niemczyk G, Wernsdörfer C, Hartung HP; "Mensch im Mittelpunkt" Study Group..

Eur J Neurol. 2009 Jun;16(6):713-20.

PMID:
19475754
5.

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.

Hadjimichael O, Vollmer T, Oleen-Burkey M; North American Research Committee on Multiple Sclerosis..

Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.

6.

Fatigue, depression and progression in multiple sclerosis.

Koch M, Uyttenboogaart M, van Harten A, Heerings M, De Keyser J.

Mult Scler. 2008 Jul;14(6):815-22. doi: 10.1177/1352458508088937. Epub 2008 Jun 5.

PMID:
18535019
7.

A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue.

van Kessel K, Moss-Morris R, Willoughby E, Chalder T, Johnson MH, Robinson E.

Psychosom Med. 2008 Feb;70(2):205-13. doi: 10.1097/PSY.0b013e3181643065. Epub 2008 Feb 6.

PMID:
18256342
8.

Brain-immune communication psychoneuroimmunology of multiple sclerosis.

Kern S, Ziemssen T.

Mult Scler. 2008 Jan;14(1):6-21. Epub 2007 Sep 19. Review.

PMID:
17881389
9.
10.

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators..

Ann Neurol. 2007 Oct;62(4):335-46.

PMID:
17696126
11.

Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being.

Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U.

Psychother Psychosom. 2007;76(4):226-33.

PMID:
17570961
12.

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients.

Simone IL, Ceccarelli A, Tortorella C, Bellacosa A, Pellegrini F, Plasmati I, De Caro MF, Lopez M, Girolamo F, Livrea P.

Health Qual Life Outcomes. 2006 Dec 12;4:96.

13.
14.

Depression in multiple sclerosis: a review.

Siegert RJ, Abernethy DA.

J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):469-75. Review.

15.

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group.

Osoba D, Bezjak A, Brundage M, Zee B, Tu D, Pater J; Quality of Life Committee of the NCIC CTG..

Eur J Cancer. 2005 Jan;41(2):280-7.

PMID:
15661554
16.
17.

Mindfulness-based stress reduction and health benefits. A meta-analysis.

Grossman P, Niemann L, Schmidt S, Walach H.

J Psychosom Res. 2004 Jul;57(1):35-43.

PMID:
15256293
18.

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a.

Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, Cazzato G.

J Neurol Sci. 2003 Dec 15;216(1):113-8.

PMID:
14607312
19.

Effects of psychological group therapy in patients with multiple sclerosis.

Tesar N, Baumhackl U, Kopp M, Günther V.

Acta Neurol Scand. 2003 Jun;107(6):394-9.

PMID:
12757470
20.

[Quality of life in patients with remitting-relapsing multiple sclerosis in Germany].

Haupts M, Elias G, Hardt C, Langenbahn H, Obert H, Pöhlau D, Sczesni B, von Wussow P.

Nervenarzt. 2003 Feb;74(2):144-50. German.

PMID:
12596015

Supplemental Content

Support Center